PMID: 8446612Mar 1, 1993Paper

Glucokinase mutations associated with non-insulin-dependent (type 2) diabetes mellitus have decreased enzymatic activity: implications for structure/function relationships

Proceedings of the National Academy of Sciences of the United States of America
M Gidh-JainD Cohen


The glycolytic enzyme glucokinase plays an important role in the regulation of insulin secretion and recent studies have shown that mutations in the human glucokinase gene are a common cause of an autosomal dominant form of non-insulin-dependent (type 2) diabetes mellitus (NIDDM) that has an onset often during childhood. The majority of the mutations that have been identified are missense mutations that result in the synthesis of a glucokinase molecule with an altered amino acid sequence. To characterize the effect of these mutations on the catalytic properties of human beta-cell glucokinase, we have expressed native and mutant forms of this protein in Escherichia coli. All of the missense mutations show changes in enzyme activity including a decrease in Vmax and/or increase in Km for glucose. Using a model for the three-dimensional structure of human glucokinase based on the crystal structure of the related enzyme yeast hexokinase B, the mutations map primarily to two regions of the protein. One group of mutations is located in the active site cleft separating the two domains of the enzyme as well as in surface loops leading into this cleft. These mutations usually result in large reductions in enzyme activity. The second grou...Continue Reading


Apr 27, 1979·Science·C M AndersonT A Steitz
Aug 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·M StoffelS Lesage
Aug 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·Y TanizawaM A Permutt
Jan 1, 1990·Preparative Biochemistry·I MiwaJ Okuda
Dec 15, 1989·Biochemical and Biophysical Research Communications·C T ChienS J Pilkis
May 5, 1986·Journal of Molecular Biology·F W Studier, B A Moffatt
Jan 1, 1982·Comparative Biochemistry and Physiology. B, Comparative Biochemistry·T Ureta
Jan 1, 1963·Advances in Enzyme Regulation·S WEINHOUSEH P MORRIS

❮ Previous
Next ❯


Mar 1, 1996·Diabetologia·R W TaylorM Walker
Jun 1, 1994·Journal of Bioenergetics and Biomembranes·D C Wallace
May 22, 2007·Mammalian Genome : Official Journal of the International Mammalian Genome Society·Peter L OliverKay E Davies
Jun 1, 1996·Mammalian Genome : Official Journal of the International Mammalian Genome Society·B E HaywardD T Bonthron
Jan 1, 1994·Life Sciences·S S FajansK S Polonsky
Dec 1, 1994·Trends in Biochemical Sciences·S EfratH F Lodish
Dec 7, 2000·Diabetes Research and Clinical Practice·J H NamK B Huh
Nov 25, 1998·Comparative Biochemistry and Physiology. Part C, Pharmacology, Toxicology & Endocrinology·T AraiT Washizu
Jul 1, 1995·Baillière's Clinical Endocrinology and Metabolism·T J Aitman, J A Todd
May 14, 1999·Trends in Endocrinology and Metabolism : TEM·P Froguel, G Velho
Dec 20, 2000·Trends in Plant Science·J V Pego, S C Smeekens
Feb 16, 2010·Nature Chemical Biology·Julie A Zorn, James A Wells
Feb 28, 2001·Diabetes, Obesity & Metabolism·T M Wallace, D R Matthews
Jun 29, 2000·Diabetic Medicine : a Journal of the British Diabetic Association·T S JapC F Kwok
Jun 29, 2006·ILAR Journal·Nicole Neubauer, Rohit N Kulkarni
Mar 1, 1995·Diabetic Medicine : a Journal of the British Diabetic Association·R C PageR C Turner
Jan 1, 1996·Annual Review of Medicine·C R KahnA Doria
Mar 12, 2013·Biotechnology Research International·Nanda Kumar YellapuBhaskar Matcha
Nov 1, 1993·The Journal of Clinical Investigation·F MatschinskyT L Jetton
Mar 1, 1994·The Journal of Clinical Investigation·M M ByrneG I Bell
Jun 1, 1994·The Journal of Clinical Investigation·Y LiangF M Matschinsky
Oct 15, 1996·The Journal of Clinical Investigation·G VelhoG I Shulman
Feb 15, 1997·The Journal of Clinical Investigation·M LehtoL Groop
Jun 3, 2005·The Journal of Clinical Investigation·M Alan PermuttNancy Cox
Jun 20, 2013·The Journal of Clinical Investigation·Haiqing HuaDieter Egli
Jan 15, 2005·Treatments in Endocrinology·José TimsitGilberto Velho
Oct 29, 2003·Molecular Diagnosis : a Journal Devoted to the Understanding of Human Disease Through the Clinical Application of Molecular Biology·Gustavo Daniel FrechtelHéctor Manuel Targovnik
Dec 10, 2013·Nature Structural & Molecular Biology·Benjamin SzlykNika N Danial
Dec 10, 1999·Proceedings of the National Academy of Sciences of the United States of America·D FarrellyN Hariharan

❮ Previous
Next ❯

Related Concepts

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Hereditary Sensory Autonomic Neuropathy

Hereditary Sensory Autonomic Neuropathies are a group of inherited neurodegenerative disorders characterized clinically by loss of sensation and autonomic dysfunction. Here is the latest research on these neuropathies.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Landau-Kleffner Syndrome

Landau Kleffner syndrome (LKS), also called infantile acquired aphasia, acquired epileptic aphasia, or aphasia with convulsive disorder, is a rare childhood neurological syndrome characterized by the sudden or gradual development of aphasia (the inability to understand or express language) and an abnormal electroencephalogram. Discover the latest research on LKS here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.


Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Regulation of Vocal-Motor Plasticity

Dopaminergic projections to the basal ganglia and nucleus accumbens shape the learning and plasticity of motivated behaviors across species including the regulation of vocal-motor plasticity and performance in songbirds. Discover the latest research on the regulation of vocal-motor plasticity here.